Quantcast
Last updated on May 29, 2012 at 15:47 EDT

Rx Processing Corp. Implements Drug Interaction Software for Our Advocates

January 19, 2007
Repost This

Rx Processing Corporation (OTC:RXPC) announces in our return to operations, we complimented the offerings to include drug interaction checking software for our advocate medical profiles. Medication interaction technology targets abnormalities common in delivering prescription medications to often knowledgeable and technology empowered citizens.

Rx Processing Corp.’s drug interaction checking empowers health care providers to accurately flag harmful combinations for its advocates. This needed over sight in ordering furthers the abilities of the dispensing pharmacist to contact the prescribing doctor to adjust patient medication regimens. This compliments drug monograph information delivered to our advocates when they complete their order.

“Providing affordable health care for the under and uninsured is more complex than simply providing distribution to a market segment,” commented CEO Peter Fiorillo. “Our implementation of drug interaction checking software will save lives and stem abuse prevalent from under and uninsured citizens vendor and doctor shopping.”

O/S: 61,633,577 Float: 21,744,502 Shareholders: 446

Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients’ health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.

Safe Harbor Statement:

All statements other than statements of historical fact included in this press release are “forward-looking statements.” The forward-looking statements, including those about the company’s future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company’s control, and may yield results differing materially from those anticipated.